A Study of Human Allogeneic Bone-marrow Derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Musculoskeletal Injuries and/or Degeneration
Clinical trial NCT06074783 · RECRUITING
Trial details
- NCT number
- NCT06074783
- Sponsor
- Cellcolabs Clinical LTD.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-20
- Primary completion
- 2027-10-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.